Literature DB >> 11706021

Akt protein kinase inhibits non-apoptotic programmed cell death induced by ceramide.

Toshihiro Mochizuki1, Akio Asai, Nobuhito Saito, Sakae Tanaka, Hideki Katagiri, Tomoichiro Asano, Makoto Nakane, Akira Tamura, Yoshiyuki Kuchino, Chifumi Kitanaka, Takaaki Kirino.   

Abstract

A growing body of evidence now suggests that programmed cell death (PCD) occurs via non-apoptotic mechanisms as well as by apoptosis. In contrast to apoptosis, however, the molecular mechanisms involved in the regulation of non-apoptotic PCD remain only poorly understood. Here we show that ceramide induces a non-apoptotic PCD with a necrotic-like morphology in human glioma cells. Characteristically, the cell death was not accompanied by loss of the mitochondrial transmembrane potential, cytosolic release of cytochrome c from mitochondria, or the activation of the caspase cascade. Consistent with these characteristics, this ceramide-induced cell death was inhibited neither by the overexpression of Bcl-xL nor by the pan-caspase inhibitor zVAD-fmk. However, strikingly, the ceramide-induced non-apoptotic cell death was inhibited by the activation of the Akt/protein kinase B pathway through the expression of a constitutively active version of Akt. The results for the first time indicate that the Akt kinase, known to play an essential role in survival factor-mediated inhibition of apoptotic cell death, is also involved in the regulation of non-apoptotic PCD.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11706021     DOI: 10.1074/jbc.M106361200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  NO donor induces Nec-1-inhibitable, but RIP1-independent, necrotic cell death in pancreatic β-cells.

Authors:  Yoshiaki Tamura; Yuko Chiba; Toshihiro Tanioka; Nobuyuki Shimizu; Shohei Shinozaki; Marina Yamada; Kentaro Kaneki; Seijiro Mori; Atsushi Araki; Hideki Ito; Masao Kaneki
Journal:  FEBS Lett       Date:  2011-08-28       Impact factor: 4.124

Review 2.  Ceramide: second messenger or modulator of membrane structure and dynamics?

Authors:  Wim J van Blitterswijk; Arnold H van der Luit; Robert Jan Veldman; Marcel Verheij; Jannie Borst
Journal:  Biochem J       Date:  2003-01-15       Impact factor: 3.857

3.  Activated Ras induces cytoplasmic vacuolation and non-apoptotic death in glioblastoma cells via novel effector pathways.

Authors:  Aparna Kaul; Jean H Overmeyer; William A Maltese
Journal:  Cell Signal       Date:  2006-11-28       Impact factor: 4.315

4.  Ceramide induces non-apoptotic cell death in human glioma cells.

Authors:  Wi Hyun Kim; Chang Hwa Choi; Soo Kyung Kang; Chae Hwa Kwon; Yong Keun Kim
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

5.  Glucagon-like peptide-1 protects beta cells from cytokine-induced apoptosis and necrosis: role of protein kinase B.

Authors:  L Li; W El-Kholy; C J Rhodes; P L Brubaker
Journal:  Diabetologia       Date:  2005-05-19       Impact factor: 10.122

Review 6.  Molecular mechanisms of necrosis in glioblastoma: the role of glutamate excitotoxicity.

Authors:  Evan Noch; Kamel Khalili
Journal:  Cancer Biol Ther       Date:  2009-10       Impact factor: 4.742

7.  A receptor-interacting protein 1 (RIP1)-independent necrotic death under the control of protein phosphatase PP2A that involves the reorganization of actin cytoskeleton and the action of cofilin-1.

Authors:  Andrea Tomasella; Anne Blangy; Claudio Brancolini
Journal:  J Biol Chem       Date:  2014-08-05       Impact factor: 5.157

8.  Regulation of osteoclast apoptosis by ubiquitylation of proapoptotic BH3-only Bcl-2 family member Bim.

Authors:  Toru Akiyama; Phillippe Bouillet; Tsuyoshi Miyazaki; Yuho Kadono; Hirotaka Chikuda; Ung-Il Chung; Akira Fukuda; Atsuhiko Hikita; Hiroaki Seto; Takashi Okada; Toshiya Inaba; Archana Sanjay; Roland Baron; Hiroshi Kawaguchi; Hiromi Oda; Kozo Nakamura; Andreas Strasser; Sakae Tanaka
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

9.  Boldine: a potential new antiproliferative drug against glioma cell lines.

Authors:  Daniéli Gerhardt; Ana Paula Horn; Mariana Maier Gaelzer; Rudimar Luiz Frozza; Andrés Delgado-Cañedo; Alessandra Luiza Pelegrini; Amélia T Henriques; Guido Lenz; Christianne Salbego
Journal:  Invest New Drugs       Date:  2008-12-03       Impact factor: 3.850

10.  HMGB1 as an autocrine stimulus in human T98G glioblastoma cells: role in cell growth and migration.

Authors:  Rosaria Bassi; Paola Giussani; Viviana Anelli; Thomas Colleoni; Marco Pedrazzi; Mauro Patrone; Paola Viani; Bianca Sparatore; Edon Melloni; Laura Riboni
Journal:  J Neurooncol       Date:  2007-11-02       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.